Hepatic-specific vitamin D receptor downregulation alleviates aging-related metabolic dysfunction-associated

Feng Zhu1, Bing-Ru Lin2, Shi-Hua Lin1

  • 1Department of Geriatrics, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.

PubMed
Abstract

Insights

Aging exacerbates liver steatosis, a condition known as metabolic dysfunction-associated steatotic liver disease (MASLD). Targeting the vitamin D receptor (VDR) shows promise in treating aging-related MASLD.

Area of Science:

  • Gerontology
  • Hepatology
  • Molecular Biology

Background:

  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by abnormal lipid accumulation in liver cells.
  • MASLD prevalence increases with age, suggesting a link between aging and liver disease.
  • The vitamin D receptor (VDR) is potentially involved in the progression of MASLD.

Purpose of the Study:

  • To investigate the relationship between aging and MASLD.
  • To explore the role and mechanisms of VDR in aging-related MASLD.

Main Methods:

  • Established cellular senescence and aging mouse models.
  • Examined VDR expression changes in aging mouse livers.
  • Utilized VDR knockdown and vitamin D supplementation in senescent models.

Main Results:

  • Aging worsened hepatic steatosis in both cell and mouse models.
  • Hepatic VDR expression increased with age.
  • VDR knockdown alleviated steatosis in senescent models, while VD supplementation aggravated it in cells but not aging mice.

Conclusions:

  • Aging contributes to increased hepatic steatosis.
  • Hepatic VDR plays a role in aging-related MASLD.
  • VDR represents a potential therapeutic target for aging-related MASLD.